Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/18/2007WO2007019563A3 Methods and compositions for inhibition of vascular permeablility
10/18/2007WO2007014263A3 Octahydroisoquinoline compounds as opioid receptor modulators
10/18/2007WO2007011231A3 Use of compounds comprising fatty acid entities
10/18/2007WO2006103545A8 4-piperazinylthieno [2,3-d] pyrimidine compounds as platelet aggregation inhibitors
10/18/2007WO2006103544A8 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
10/18/2007WO2006100413A9 Novel compounds derived from 5-thioxylose and therapeutic use thereof
10/18/2007WO2006091647A3 Method of preferentially inducing the biosynthesis of interferon
10/18/2007WO2006087544A8 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
10/18/2007WO2006087543A8 Antibacterial piperidine derivatives
10/18/2007WO2006055964A3 Zolmitriptan crystal forms
10/18/2007WO2005037780A3 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds
10/18/2007WO2003061560A3 Replication competent dual-ad vectors for vaccine and immunotherapy applications
10/18/2007US20070244323 Pharmaceutical Compositions Comprising Zd6474
10/18/2007US20070244322 Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin
10/18/2007US20070244321 bis (+) 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylaminopyrimidin)-5-yl]-(3R,5S)-dihydroxy-(E)-6-heptenoate; cardiovascular disorders; CRESTOR; HMG-CoA reductase inhibitor; hyperlipidemia
10/18/2007US20070244202 Ampk Activator
10/18/2007US20070244201 Monoamine transporter inhibitors; 5-HT2a antagonists; bipolar disorders, depression, mood disorders, addictions, cognitive disorders, and neurodegenerative diseases; cis-1,2-diarylcyclopropanemthylamines
10/18/2007US20070244200 Method for triggering angiogenic response
10/18/2007US20070244199 Anti-mycobacterial formulation
10/18/2007US20070244198 Carboxylic Derivatives
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244196 Prostaglandin F2alpha derivative-containing product
10/18/2007US20070244195 Treatment methods with peroxides and tertiary amines
10/18/2007US20070244194 Carboxamido opioid compounds
10/18/2007US20070244193 Intramuscular antiviral treatments
10/18/2007US20070244192 Plant seed oils containing polyunsaturated fatty acids
10/18/2007US20070244191 Strontium salts of sulphonic acids, a process for their preparation and pharmaceutical compositions containing them
10/18/2007US20070244190 Neobritannilactone B and acetyl neobritannilactone B
10/18/2007US20070244189 Antioxidant Material, Anti-Deterioration Agent and Food or Beverage
10/18/2007US20070244188 Coadministering amprenavir, saquinavir, tipranavir, paclitaxel, or docetaxel and a spiro ortho ester-ether-substituted furocoumarin derived from citrus fruits, especially grapefruit; nontoxic
10/18/2007US20070244187 Intermediates for the Preparation of Halichondrin B
10/18/2007US20070244186 cdc25 tyrosine phosphatase inhibitors such as 5-{[2-(dimethylamino)ethyl]amino}-2-(morpholin-4-ylcarbonyl)-1,3-benzothiazole-4,7-dione, used as anticarcinogenic agents
10/18/2007US20070244185 Crystal form and pharmaceutical compositions of (+)-R-zileuton
10/18/2007US20070244184 Glycosidase inhibitors and methods of synthesizing same
10/18/2007US20070244183 Such as 3-(1,3-Dioxobenzo[e]isoindolin-2-yl)-3-(3-ethoxy-4-methoxyphenyl)propanenitrile; cancer, inflammatory bowel disease and myelodysplastic syndrome
10/18/2007US20070244182 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
10/18/2007US20070244181 Carvedilol dihydrogen phosphate dihydrate; crystal structure; x-ray patterns; mixed venous/arterial vasodilation; non-cardioselective, beta-adrenergic blocking agents; hypotensive agents, congestive heart failure; angina;water solubility; stability; prolonged G.I. bioavailabilty in pH regions
10/18/2007US20070244180 antineoplastic, antiinflammatory and analgesics; 2-[1,8-DIETHYL-6-(4-METHOXY-PHENYL)-1,3,4,9-TETRAHYDRO-PYRANO[3,4-b]INDOL-1-yl]-ETHANOL; COX inhibitors, beta-catenin inhibitors, cyclin D1 inhibitors; cytotoxic to cancer cell lines
10/18/2007US20070244179 Dihydro[1,4]dioxino[2,3-e]indazole derivatives as 5-hydroxytryptamine-6 ligands
10/18/2007US20070244178 (R)-1-(2-benzyl-2H-indazol-4-yl)-3-(5-tert-butyl-2,3-dihydro-1H-indan-1-yl)urea, for example; from 2-N-benzylbromoindazole and indanylurea
10/18/2007US20070244177 Enzyme inhibitors
10/18/2007US20070244176 Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-beta-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
10/18/2007US20070244175 Phytonutrient compositions from mushrooms or filamentous fungi and methods of use
10/18/2007US20070244174 Chemical Inhibitors of Soluble Adenylyl Cyclase (Sac)
10/18/2007US20070244173 6,7-Dihydroxy-8-Phenyl-3,6,7,8-Tetrahydro-Chromeno [7,8-d] Imidazole Derivatives and Their Use as Gastric Acid Secretion Inhibitors
10/18/2007US20070244172 Compounds for the treatment of metabolic disorders
10/18/2007US20070244171 Compounds for the treatment of metabolic disorders
10/18/2007US20070244170 Novel Pyrrole Derivatives with Angiotensin II Antagonist Activity
10/18/2007US20070244169 Glucokinase activators
10/18/2007US20070244168 Ritonavir Analogous Compound Useful as Retroviral Protease Inhibitor, Preparation of The Ritonavir Analogous Compound and Pharmaceutical Composition for The Ritonavir Analogous Compound
10/18/2007US20070244167 Method for Purificaion of Amlodipine Free Base
10/18/2007US20070244166 Pre-mixed, ready-to-use iv bolus compositions and methods of use
10/18/2007US20070244165 Method for Identifying and Producing Effectors of Calmodulin-Dependent Peptidyl-Prolyl Cis/Trans Isomers
10/18/2007US20070244164 Pyridone sulfonamides and pyridone sulfamides as mek inhibitors
10/18/2007US20070244163 Fused Ring Thrombin Receptor Antagonists
10/18/2007US20070244162 Substituted aromatic heterocyclic compounds as fungicides
10/18/2007US20070244161 Novel mercaptophenyl naphthyl methane compounds and synthesis thereof
10/18/2007US20070244160 6-11 Bicyclic Ketolide Derivatives
10/18/2007US20070244159 including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), such as 1-(Benzo[d][1,3]dioxol-5-yl)-N-(2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, used for the treatment of genetic disorders such as cystic fibrosis, emphysema, hemochromatosis and protein C deficiency
10/18/2007US20070244158 Piperdine Compound and Process for Preparing the Same
10/18/2007US20070244157 Crystalline form of a benzimidazole-carboxamide medicinal compound
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007US20070244155 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
10/18/2007US20070244154 Substituted Tricyclic Benzimidazoles
10/18/2007US20070244152 Use of an Nk3 Antagonist for the Treatment of Bipolar Disorders
10/18/2007US20070244151 Opiate Intermediates and Methods of Synthesis
10/18/2007US20070244150 Muscarinic Acetylcholine Receptor Antagonists
10/18/2007US20070244149 Tropane analogs and methods for inhibition of monoamine transport
10/18/2007US20070244148 Imidazo 4,5-C Pyridine Compounds and Methods of Antiviral Treatment
10/18/2007US20070244147 Therapeutic agent for schizophrenia
10/18/2007US20070244146 Thienopyridines as IKK inhibitors
10/18/2007US20070244145 Cyclic Amine Compound
10/18/2007US20070244144 Process for the preparation of desloratadine
10/18/2007US20070244143 Modulation of neurogenesis by nootropic agents
10/18/2007US20070244142 Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
10/18/2007US20070244141 Compounds for the treatment of metabolic disorders
10/18/2007US20070244140 Anilino-pyrimidine phenyl and benzothiophene analogs
10/18/2007US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244137 Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes
10/18/2007US20070244136 Quinazoline Derivatives
10/18/2007US20070244135 Sulfonamides
10/18/2007US20070244134 Selective antagonists of A2A adenosine receptors
10/18/2007US20070244133 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine
10/18/2007US20070244132 Fused Heterocyclic Compound
10/18/2007US20070244131 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
10/18/2007US20070244130 Compounds and Compositions as Ppar Modulators
10/18/2007US20070244129 Process for the preparation of an isopropanol solvate of a glucokinase activator
10/18/2007US20070244128 5-lipoxygenase-activating protein (flap) inhibitors
10/18/2007US20070244127 Stable Dosage Form of Phenylalanine Derivatives
10/18/2007US20070244126 small-molecules that can control the release of inflammatory mediators and inhibit leukocyte recruitment; antiinflammatory agents; [5-(5-Fluoro-4-methyl-1H-benzoimidazol-2-yl)-4-methyl-pyrimidin-2-yl]-[3-(1-methyl-piperidin-4-yl)-propyl]-amine
10/18/2007US20070244125 5-amido-indole-2-carboxamide derivatives
10/18/2007US20070244124 For therapy of multi-drug resistant disease; combination therapy; anticarcinogenic agent; leukemia; hydrochloride salt; obtained with copper radiation source
10/18/2007US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors
10/18/2007US20070244122 Derivatives of sulindac, use thereof and preparation thereof
10/18/2007US20070244120 Inhibition of raf kinase using substituted heterocyclic ureas
10/18/2007US20070244119 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
10/18/2007US20070244118 Cyclic Amide Derivative, and Its Production and Use
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007US20070244116 c-MET MODULATORS AND METHOD OF USE
1 ... 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 ... 7860